Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
Paying the right price for pharmaceuticals: a case study of why the comparator matters
Ist Teil von
Australian health review, 2011-08, Vol.35 (3), p.267
Ort / Verlag
Australia
Erscheinungsjahr
2011
Quelle
MEDLINE
Beschreibungen/Notizen
This article considers the pricing policy for pharmaceuticals in Australia, which is widely seen as having achieved low drug prices. However, compared to New Zealand, the evidence implies that Australia might have improved its performance significantly if it had proactively sought market best pricing. The Australian record suggests that the information sought by authorities may not be sufficient for optimal pricing and that the economic evaluation of pharmaceuticals may be neither necessary nor sufficient for achieving this goal.